Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH vs rivaroxaban for thromboprophylaxis in surgical gastrointestinal cancer
TCTR20190712003Not yet recruiting
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of rivaroxaban and low molecular weight heparin calcium in venous thromboembolism (VTE) (2 arms), sponsored by Ramathibodi Hospital. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
rivaroxabanlow molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20190712003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190712003.